The recent resurgence of surgical treatment of Parkinson's disease has gene
rated enormous interest in the scientific community and with the general pu
blic. Both ablation (pallidotomy, thalamotomy), deep brain stimulation (tha
lamus, pallidum, subthalamus), and neural transplantation (human, porcine)
have been demonstrated to be effective for specific subsets of Parkinson's
disease patients. Future studies need to define better the ideal target sit
es and lesion volume of ablation and stimulation procedures, and optimising
graft survival in neural transplantation. Numerous potential surgical inte
rventions are currently being evaluated.